Allergy, Asthma, and Atopic Eczema in Finland | MicrobiomeTrials← Back to trialsNCT06330974
Allergy, Asthma, and Atopic Eczema in Finland
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2032-12
Enrollment target: 1,600,000 participants Locations- Tampere University, Tampere, Finland
Other microbiome trials you might be interested in
Food Allergy in Children
The aim is to study whether a multiallergen oral immunotherapy (OIT) strategy with slow up-dosing and low treatment dose…
Multiple LocationsEst. completion Dec 2032
Asthma AcuteCOPD Exacerbation Acute
A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in par…
Miami, United StatesEst. completion Dec 2026